Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
Clinical trial NCT03982797 · UNKNOWN
Trial details
- NCT number
- NCT03982797
- Sponsor
- Biofabri, S.L
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2021-04-03
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.